| |
Squamous Histology |
Transitional and Papillary Histology |
Other Histologies |
| |
Renal Pelvis |
Ureter |
Both Sites |
Renal Pelvis |
Ureter |
Both Sites |
Renal Pelvis |
Ureter |
Both Sites |
| Gender
Men
Women |
56 (46.3%)
65 (53.7%) |
42 (53.9%)
36 (46.1%) |
98 (49.3%)
101 (50.7%) |
4396 (60.4%)
2883 (39.6%) |
3377 (66.0%)
1739 (34.0%) |
7,773 (62.7%)
4,622 (37.3%) |
190 (60.1%)
126 (39.9%) |
192 (63.3%)
111 (36.6%) |
382 (61.7%)
237 (38.3%) |
| Race
Caucasian
Blacks
Hispanics
Asian/Other |
102 (84.3%)
7 (5.8%)
3 (2.5%)
9 (7.4%) |
62 (79.5%)
5 (6.4%)
4 (5.1%)
7 (8.9%) |
164 (82.4%)
12 (6.0%)
7 (3.5%)
16 (8.1%) |
6376 (87.6%)
308 (4.2%)
200 (2.8%)
395 (5.4%) |
4574 (89.4%)
131 (2.6%)
117 (2.3%)
294 (5.8%) |
10,950 (88.3%)
439 (3.5%)
317 (2.6%)
689 (5.6%) |
260 (82.3)
24 (7.6%)
16 (5.0%)
16 (5.0%) |
264 (87.1%)
19 (6.3%)
5 (1.7%)
15 (5.0%) |
524 (84.6%)
43 (7.0%)
21 (3.4%)
31 (5.0%) |
| Age Group
30-49 years old
50-74 years old
>75 years old |
11 (9.1%)
60 (49.6%)
50 (41.3%) |
4 (5.1%)
51 (65.4%)
23 (29.5%) |
15 (7.5%)
111 (55.8%)
73 (36.7%) |
438 (6.0%)
4199 (57.7%)
2642 (36.3%) |
166 (3.2%)
2945 (57.6)
2005 (39.2%) |
604 (4.9%)
7,144 (57.6%)
4,647 (37.5%) |
42 (13.3%)
174 (55.0%)
100 (31.7%) |
17 (5.6%)
155 (51.2%)
131 (43.23%) |
59 (9.5%)
329 (53.2%)
231 (37.3%) |
| Decade of diagnosis
1973-1979
1980-1989
1990-1999
2000-2004 |
35 (28.9%)
39 (32.2%)
34 (28.1%)
13 (10.7%) |
16 (20.5%)
30 (38.5%)
21 (26.9%)
11 (14.1%) |
51 (25.6%)
69 (34.7%)
55 (27.6%)
24 (12.1%) |
1251 (17.2%)
2142 (29.4%)
2524 (34.7%)
1362 (18.7%) |
751 (14.7%)
1486 (29.0%)
1836 (35.9%)
1043 (20.4%) |
2,002 (16.2%)
3,628 (29.3%)
4,360 (35.2%)
2,405 (19.4%) |
82 (25.9%)
92 (29.1%)
96 (30.4%)
46 (14.6%) |
53 (17.5%)
103 (34.0%)
95 (31.4%)
52 (177.2%) |
135 (21.8%)
195 (31.5%)
191 (30.9%)
98 (15.8%) |
| Stage
In situ
Local
Regional
*-LN+
*-LN-
*-Not available
Distal
Insuff. Inform. |
1 (0.8%)
14 (11.6%)
56 (46.3%)
5(8.9%)
4(7.1%)
47 (83.9%)
40 (33.1%)
10 (8.3%) |
3 (3.9%)
15 (19.2%)
44 (56.4%)
2(4.5%)
1(2.3%)
93.2%)
13 (16.7%)
3 (3.9%) |
4 (2.0%)
29 (14.6%)
100 (50.3%)
7(7.0%)
5(5.0%)
88(88.0%)
53 (26.6%)
13 (6.5%) |
1158 (15.9%)
2502 (34.4%)
2666 (36.6%)
195(7.3%)
222(8.3%)
2,249(84.4%)
650 (8.9%)
303 (4.2%) |
1261 (24.7%)
1757 (34.3%)
1606 (31.4%)
89(5.5%)
142(8.8%)
1,375(85.6%)
260 (5.0%)
232 (4.5%) |
2,419 (19.5%)
4,259 (34.4%)
4,272 (34.5%)
284(6.7%)
364(8.5%)
3,624(84.8%)
910 (7.3%)
535 (4.3%) |
16 (5.0%)
85 (26.9%)
78 (24.7%)
10(12.8%)
9(11.5%)
59(75.6%)
82 (26.0%)
55 (17.4%) |
102 (33.7%)
39 (12.9%)
49 (16.2%)
3(6.1%)
2(4.1%)
44(89.8%
37 (12.2%)
76 (25.1%) |
118 (19.1%)
124 (20.0%)
127 (20.5%)
13(10.2%)
11(8.7%)
103(81.1%)
119 (19.2%)
131 (21.2%) |
| Surgery
Yes
No |
94 (77.7%)
27 (22.3%) |
62 (79.5%)
16 (20.5%) |
156 (78.4%)
43 (21.6%) |
6561 (90.1%)
718 (9.9%) |
4622 (90.3%)
494 (9.7%) |
11,183 (90.2%)
1,212 (9.8%) |
188 (59.5%)
128 (40.5%) |
181 (59.7%)
122 (40.3%) |
369 (59.6%)
250 (40.4%) |
| Radiation
Yes
No |
19 (15.70%)
102 (84.30%) |
24 (30.77%)
54 (69.23%) |
43 (21.6%)
156 (78.4%) |
425 (5.8%)
6854 (94.2%) |
357 (7.0%)
4759 (93.0%) |
782 (6.3%)
11,613 (93.7%) |
39 (12.3%)
277 (87.7%) |
33 (10.9%)
270 (89.1%) |
72 (11.6%)
547 (88.4%) |
*The percentage figure refers to the total amount of cases in the regional disease category. The table above displays the distribution of clinically relevant disease characteristics for patients with UUT malignancies
across the different histologies, i.e. transitional cell, squamous cell and others( mainly small cell, sarcomatoid and undifferentiated carcinomas).